A questionnaire-based knowledge, attitude and practice study to determine the awareness of pharmacovigilance among the health care professionals in a tertiary care hospital of West Bengal
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20214091Keywords:
Pharmacovigilance, Adverse drug reaction, Awareness, Knowledge, Practice, UnderreportingAbstract
Background: Pharmacovigilance programs have been introduced to keep an eye on adverse drug reactions and safe use of drugs. All Healthcare professionals (HCPs) should report each and every adverse events which they come across. Pharmacovigilance programme of India is running actively since 2010 but India contributes only 2% of Adverse drug reactions (ADR’s) reported worldwide. There is need to monitor awareness of HCP’s about pharmacovigilance to achieve the goals. Such studies from peripheries of Eastern India are lacking. The aim of the study was to assess the knowledge, attitude and practice and overall awareness among HCP’s about pharmacovigilance and to understand actual barriers of ADR reporting.
Methods: A cross-sectional questionnaire-based study was done in Burdwan Medical College and Hospital. Ninety-nine HCP’s completed the pre-designed questionnaire. There were 15 questions to assess the awareness and cause(s) of underreporting. Data were analysed using appropriate statistical software.
Results: We analysed data of 67 doctors and 32 nurses. We found, 67.2% doctors and 59.4% nurses knew definition of pharmacovigilance. About half HCP’s had knowledge about existing pharmacovigilance committee in our hospital. Almost all HCP’s felt ADR reporting is necessary. Surprisingly 88.1% doctors and 46.9% nurses experienced ADR at least once but 25.4% and 3.1% reported them respectively. For knowledge and practice related questions, correct responses were significantly higher for doctors. Most common discouraging factors regarding ADR reporting were, didn’t know how to report (52.5%) where to report (41.4%).
Conclusions: Attitude of HCP’s towards pharmacovigilance activities was appreciable and combining it with periodic sensitizing programs, and training sessions will increase the knowledge, clear doubts about ADR reporting and improve the awareness about pharmacovigilance.
References
Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279(15):1200-5.
WHO. Quality Assurance and Safety of Medicines Team. Safety of medicines: a guide to detecting and reporting adverse drug reactions: why health professionals need to take action, 2002. Available at: https://apps.who.int/iris/handle/1066578. Accessed on 20 September 2021.
Upadhyaya P, Seth V, Moghe VV, Sharma M, Ahmed M. Knowledge of adverse drug reaction reporting in first year postgraduate doctors in a medical college. Ther Clin Risk Manag. 2012;8:307-12.
Remesh A. Identifying the reasons for under reporting of ADR: A cross sectional survey. Res J Pharm Biol Chem Sci. 2012;3:1379-86.
Xu H, Wang Y, Liu N. A hospital-based survey of healthcare professionals in the awareness of pharmacovigilance. Pharmacoepidemiol Drug Saf. 2009;18(7):624-30.
Bharadwaj V, Budania N, Mondal A, Yadav V, Sharma P. A Survey to Assess the Awareness of Adverse Drug Reactions and Pharmacovigilance Practices among Healthcare Professionals in a Tertiary Care Hospital. Int J Med Res Prof. 2016;2(1):134-7.
Gupta SK, Nayak RP, Shivaranjani R, Vidyarthi SK. A questionnaire study on the knowledge, attitude, and the practice of pharmacovigilance among the healthcare professionals in a teaching hospital in South India. Perspect Clin Res. 2015;6(1):45-52.
Ramesh M, Parthasarathi G. Adverse drug reaction reporting: the attitudes and the perceptions of the medical practitioners. Asian J Pharma Clin Res. 2009;2(2):10-4.
Feely J, Moriarty S, Connor P. Stimulating reporting of adverse drug reactions by using a fee. BMJ. 1990;300(6716):22-3.
Smith CC, Bennett PM, Pearce HM, Harrison PI, Reynolds DJ, Aronson JK, et al. Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines. Br J Clin Pharmacol. 1996;42(4):423-9.
Desai CK, Iyer G, Panchal J, Shah S, Dikshit RK. An evaluation of knowledge, attitude, and practice of adverse drug reaction reporting among prescribers at a tertiary care hospital. Perspect Clin Res. 2011;2(4):129-36.
Kanwar S, Mathur SK, Yadav D. A questionnaire based study on the knowledge, attitude and practice of PV among the medical officers working in peripheral areas of Ajmer district, Rajasthan (India). Gal Int J Health Sci Res. 2020;5(1):84-8.
Srinivasan V, Sheela D, Mridula D. Knowledge, Attitude and Practice of PV among the Healthcare Professionals in a Tertiary Care Hospital – A Questionnaire Study. Biomed Pharmacol J. 2017;10(3):1441-7.
Vakade KP, Sangisetti VM, Binayke MV, Abhavathi VN, Nayak BB. An evaluation of knowledge, attitude and practice of PV among interns in a tertiary care teaching hospital of North Maharashtra. Int J Basic Clin Pharmacol. 2016;5:2321-5.
Sachidananda AMN, Sachidananda AU. Awareness of Adverse Drug Reaction Monitoring and Practice among Student Nurses. Indian J Pharm Pharmacol. 2016;3(3):121-6.
Kunnoor NS, Sharanabasappa, Lohit K. Perception of doctors towards Adverse Drug Reaction (ADR) reporting: a cross sectional survey using a validated questionnaire. Int J Basic Clin Pharmacol. 2017;6:2671-5.
